NICOLE MCDERMOTT: Open Payments
NPI 1811918345 · BETHPAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 16 payments from 10 companies in 2025. Trend: 2023 $579 · 2024 $951 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 3 | $404 |
| Dexcom, Inc. | 4 | $173 |
| Madrigal Pharmaceuticals | 1 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $130 |
| Novo Nordisk Inc | 1 | $118 |
| ABBVIE INC. | 2 | $53 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
| CeQur Corporation | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: iLet Bionic Pancreas, Dexcom G6 Transmitter, REZDIFFRA, Kerendia, Wegovy, RINVOQ, Yorvipath, ISTURISA.
Industry payments across NY — which companies pay providers there.
